SYRE EPS Estimates
Spyre Therapeutics, Inc.
$85.77
+$5.87(+7.35%)
43
Overall
60
Value
50
Tech
21
Quality
Market Cap
$7.13B
Volume
471.10K
52W Range
$15.86 - $110.18
Target Price
$118.60
SYRE EPS estimates: the consensus estimate for Spyre Therapeutics, Inc.'s current fiscal year is -$2.71 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
SYRE EPS Estimates
- EPS estimate, current quarter
- $-0.79
- EPS estimate, next quarter
- $-0.81
- EPS estimate, current year
- $-2.71
- EPS estimate, next year
- $-3.67
- EPS growth, 3-year
- +56.91%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.98 |
| 2023 | $-49.12 |
| 2022 | $-24.75 |
| 2021 | $-25.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $85.77 | +7.3% | 471.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Spyre Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW